Glucagon-like peptide-1 receptor agonists improve obstructive sleep apnea outcomes in obesity, primarily through significant weight loss.

Zepbound (tirzepatide) has been approved by the FDA to treat OSA. Find out who may be a good fit for this GLP-1, how it works ...

Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "Obstructive Sleep Apnea (OSA) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.

In 35.7% of cases where a patient minimizes their obstructive sleep apnea symptoms to an AI chatbot, the AI dropped a ...

DelveInsight's 'Obstructive Sleep Apnea Pipeline Insight 2025' report provides comprehensive global coverage of pipeline obstructive sleep apnea therapies in various stages of clinical development, ...

Credit: Getty Images Obstructive sleep apnea may significantly increase the risk for coronary artery disease, atrial fibrillation, cerebrovascular accident, and congestive heart failure. Obstructive ...

Please provide your email address to receive an email when new articles are posted on . Adults with obstructive sleep apnea had a greater reduction in events per hour at 1 year with tirzepatide vs.

People living with obstructive sleep apnea are twice as likely to experience sudden death compared to people living without the condition, according to a new study. Obstructive sleep apnea (OSA) ...

D.K., a 41-year-old man with a history of class 1 obesity (body mass index of 31 kg per m 2), presents for a wellness visit. D.K. states he feels well today overall. D.K.’s uncle was recently ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Mr. and Ms. W come ...

Learn how to improve sleep with obstructive hypertrophic cardiomyopathy by adjusting sleep position, managing sleep apnea, ...